Prucalopride
Drug used to treat chronic constipation
Prucalopride
Prucalopride, sold under brand names Resolor and Motegrity among others, is a medication acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements. Prucalopride was approved for medical use in the European Union in 2009, in Canada in 2011, and in the United States in December 2018.
Read on Wikipedia · Image Vaccinationist, Public domain
Open boosters, collect cards and trade them. Free to play.
Play for free